Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of DirectorsPR Newswire (Wed, 8:15PM)
-
PR Newswire (Mon, 5:00PM)
-
PR Newswire (May 10, 2013)
-
-
-
-
PR Newswire (May 2, 2013)
-
PR Newswire (May 2, 2013)
-
PR Newswire (May 1, 2013)
-
-
PR Newswire (Apr 25, 2013)
-
PR Newswire (Apr 16, 2013)
-
PR Newswire (Apr 10, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
Valeant Pharmaceuticals: An Attractive Buy At Current LevelsDavid Zanoni • Mon, Aug 6, 2012 -
Valeant: Buy This 'Spring Loaded' Stock NowVatalyst • Sun, Jul 1, 2012 -
-
-
-
Valeant Will Leap Higher On New AcquisitionDividend Kings • Wed, Apr 18, 2012
-
-
Valeant: Ready To Move On Increased R&DStock Croc • Thu, Apr 12, 2012 -
Valeant: Zovirax, New Acquisitions Are Big Money-SpinnersValueMax • Thu, Apr 12, 2012 -
Valeant Headed Into High Growth PhaseRy Frank • Tue, Apr 10, 2012
-
-
Valeant Pharmaceuticals International Q4 2008 Earnings Call TranscriptTue, Feb 24, 2009
-
Medicis Pharmaceutical Corporation Q3 2008 Earnings Call TranscriptTue, Nov 11, 2008
-
Medicis Pharmaceutical Corporation Q2 2008 Earnings Call TranscriptTue, Aug 19, 2008 • 1 Comment
-
Valeant Pharmaceuticals International Q2 2008 Earnings Call TranscriptMon, Aug 11, 2008
-
Medicis Pharmaceutical Corporation Q1 2008 Earnings Call TranscriptFri, May 30, 2008
-
Valeant Pharmaceuticals International Q1 2008 Earnings Call TranscriptTue, May 13, 2008
-
Medicis Pharmaceutical Corp. Q4 2007 Earnings Call TranscriptMon, Mar 10, 2008
-
Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of DirectorsPR Newswire (Wed, 8:15PM)
-
PR Newswire (Mon, 5:00PM)
-
PR Newswire (May 10, 2013)
-
at MarketWatch.com (May 9, 2013)
-
PR Newswire (May 2, 2013)
-
PR Newswire (May 2, 2013)
-
PR Newswire (May 1, 2013)
-
at MarketWatch.com (Apr 30, 2013)
-
at CNBC.com (Apr 29, 2013)
-
at MarketWatch.com (Apr 29, 2013)
-
at CNBC.com (Apr 29, 2013)
-
PR Newswire (Apr 25, 2013)
-
PR Newswire (Apr 16, 2013)
-
PR Newswire (Apr 10, 2013)
-
PR Newswire (Apr 4, 2013)
-
at MarketWatch.com (Apr 3, 2013)
VRX vs. ETF Alternatives
Company Description
We are a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products. Our specialty pharmaceutical and OTC products are marketed under brand names and are sold in the United States, Canada, Australia and New Zealand, where we... More
